TriSalus Research Development from 2010 to 2026

TLSI Stock   5.44  0.05  0.91%   
TriSalus Life's Research Development is increasing with slightly volatile movements from year to year. Research Development is estimated to finish at about 22.9 M this year. For the period between 2010 and 2026, TriSalus Life, Research Development quarterly trend regression had mean deviation of  3,401,197 and range of 15.6 M. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
20.3 M
Current Value
22.9 M
Quarterly Volatility
4.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TriSalus Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TriSalus Life's main balance sheet or income statement drivers, such as Tax Provision of 7.4 K, Interest Income of 279.1 K or Interest Expense of 3.7 M, as well as many indicators such as Price To Sales Ratio of 4.93, Dividend Yield of 0.0 or Days Sales Outstanding of 47.59. TriSalus financial statements analysis is a perfect complement when working with TriSalus Life Valuation or Volatility modules.
  
Build AI portfolio with TriSalus Stock
Check out the analysis of TriSalus Life Correlation against competitors.

Latest TriSalus Life's Research Development Growth Pattern

Below is the plot of the Research Development of TriSalus Life Sciences over the last few years. It is TriSalus Life's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TriSalus Life's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

TriSalus Research Development Regression Statistics

Arithmetic Mean16,633,181
Geometric Mean16,186,418
Coefficient Of Variation26.88
Mean Deviation3,401,197
Median14,224,000
Standard Deviation4,470,884
Sample Variance20T
Range15.6M
R-Value0.66
Mean Square Error12T
R-Squared0.44
Significance0
Slope586,359
Total Sum of Squares319.8T

TriSalus Research Development History

202622.9 M
202520.3 M
202417.7 M
202329.8 M
202221.4 M

About TriSalus Life Financial Statements

Investors use fundamental indicators, such as TriSalus Life's Research Development, to determine how well the company is positioned to perform in the future. Although TriSalus Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development20.3 M22.9 M

Currently Active Assets on Macroaxis

When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:
Check out the analysis of TriSalus Life Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.12)
Revenue Per Share
1.217
Quarterly Revenue Growth
0.574
Return On Assets
(0.61)
Return On Equity
(4.96)
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.